| 41. | Besides corticosteroids, various other therapeutic areas have been pursued such as soft beta-blockers, soft opioid analgetics, soft estrogens, soft beta-agonists, soft anticholinergics, soft antimicrobials, soft antiarrhythmic agents, soft angiotensin converting enzyme ( ACE ) inhibitors, soft dihydrofolate reductase ( DHFR ) inhibitors, soft cancineurin inhibitors ( soft immunosuppressants ), soft matrix metalloproteinase ( MMP ) inhibitors, soft cytokine inhibitors, soft cannabinoids, soft Ca 2 + channel blockers ( see for a recent review ).
|
